Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
LSFG Repro
Prospective, Non-randomised, Non-controlled Study of Reproducibility of Blood Flowmetry in Human Retina Using the Nidek Laser Speckle Flowgraphy LSFG-NAVI System
1 other identifier
observational
44
1 country
1
Brief Summary
In addition to intraocular pressure blood perfusion pressure in the optic nerve is an important factor determing the cause of glaucoma. Increasing evidence suggests that in glaucoma patients retinal blood may be decreased.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 3, 2019
CompletedFirst Posted
Study publicly available on registry
July 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedJune 5, 2023
June 1, 2023
1.6 years
July 3, 2019
June 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Coefficients of variation (COV)
COVs from 3 measurements of ocular blood flow at visit 1 of observer 1 and at visit 1 of observer 1 and from observer 2 will be computed.
1 month
intraclass correlation coefficients (ICCs)
Intraobserver ICC, interobserver ICC, and inter-session ICC will be computed
1 month
Secondary Outcomes (4)
Cofounder
1 month
Cofounder
1 month
Cofounder
1 month
Cofounder
1 month
Study Arms (3)
open-angle glaucoma
patients with a diagnosis of open-angle glaucoma, i.e. untreated IOP \>21mmHg plus glaucomatous disc changes and/or visual field defects typical for glaucoma
normal tension glaucoma
patients with a diagnosis of normal tension glaucoma, i.e. untreated IOP \</=21mmHg plus glaucomatous disc changes and/or visual field defects typical for glaucoma
healthy controls
individuals with normal optic disc and IOP \</21mmHg and normal visual fields
Interventions
Non-invasive, real-time imaging and measurement of ocular blood flow of the optic disc and peripapillary region
Eligibility Criteria
3 groups as described above will be recruted from the outpatient department of the Ophthalmology Department at the UniversityHospital Zurich, Zurich, Switzerland and the Ophthalmology Department at the Cantonal Hospital Aarau, Aarau, Switzerland
You may qualify if:
- signed Patient Informed Consent form
- Be at least 18 years old
- Diagnosis of primary or secondary open-angle glaucoma or normal tension glaucoma or healthy controls
You may not qualify if:
- Age \< 18 years
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
- No vulnerable participants will be included in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Ophthalmology
Zurich, Canton of Zurich, 8091, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marc Töteberg-Harms, MD, FEBO
UniversityHospital Zurich, Department of Ophthalmology, Zurich, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2019
First Posted
July 10, 2019
Study Start
July 1, 2019
Primary Completion
February 9, 2021
Study Completion
December 31, 2021
Last Updated
June 5, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share